A chemical probe for BAG1 targets androgen receptor-positive prostate cancer through oxidative stress signaling pathway-Reference-Cited by-同舟云学术

A chemical probe for BAG1 targets androgen receptor-positive prostate cancer through oxidative stress signaling pathway

Published:2022-05 Issue:5 Volume:25 Page:104175
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Kuznik Nane C.,Solozobova Valeria,Lee Irene I.,Jung Nicole,Yang Linxiao,Nienhaus Karin^ORCID,Ntim Emmanuel A.,Rottenberg Jaice T.,Muhle-Goll Claudia,Kumar Amrish Rajendra,Peravali Ravindra^ORCID,Gräßle Simone,Gourain Victor,Deville Célia,Cato Laura,Neeb Antje,Dilger Marco,Cramer von Clausbruch Christina A.,Weiss Carsten,Kieffer Bruno,Nienhaus G. Ulrich,Brown Myles^ORCID,Bräse Stefan,Cato Andrew C.B.^ORCID

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference83 articles.

1. Co-chaperones in targeting and delivery of misfolded proteins to the 26S proteasome;Abildgaard;Biomolecules,2020

2. Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement;Altenhöfer;Antioxid. Redox Signal.,2015

3. MICALs;Alto;Curr. Biol.,2018

4. Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage;Arosio;Biochim. Biophys. Acta,2010

5. A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model;Basu;Cancer Res.,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate Cancer;Molecular Cancer Therapeutics;2024-02-27

2. Caveolae disassemble upon membrane lesioning and foster cell survival;iScience;2024-02

3. Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy;Molecular Cancer;2024-01-09

4. Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy;Cancer Research Communications;2023-07-27

5. Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers;Biomolecules;2022-12-15